Tradestie Institutional Equity Comparison Engine

MEDX vs GTOP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MEDX Overall Edge

MEDX Captures Institutional Edge (1โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Horizon Kinetics Medical ETF (MEDX) driven by superior Momentum & Technical. Fundamentally, MEDX trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus GTOP at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MEDX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GTOP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MEDX N/M vs GTOP N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner MEDX
1Y +18.6% vs +10.4% ยท 52W Pos 87% vs 51%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MEDX NASDAQ
Horizon Kinetics Medical ETF
Institutional Equity
$37.66
-0.92% 1D
Market Cap N/A
1M Return +4.61%
1Y Return +18.61%
Forward P/E N/M
Unified AI Score
42.6 / 100 HOLD
Tech 42.0 Fund 45.0 Flow 50.0 Mom 46.0
GTOP US Equity
GTOP
Institutional Equity
$44.15
-3.03% 1D
Market Cap N/A
1M Return -8.97%
1Y Return +10.37%
Forward P/E N/M
Unified AI Score
55.3 / 100 HOLD
Tech 58.0 Fund 61.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MEDX +18.61% GTOP +10.37% Spread: +3.02 pp (MEDX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MEDX TTM Op. Margin: N/A GTOP TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MEDX vs GTOP. Trailing 12-month operating profitability (MEDX N/A vs GTOP N/A) and valuation multiples (MEDX N/M vs GTOP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MEDX (2) vs GTOP (1)
Institutional Metric MEDX GTOP Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 87% ($32โ€“$39) 51% ($34โ€“$53) Stronger Trend MEDX
Beta / 30D Volatility Risk Regime 0.34ฮฒ ยท 19% Vol 1.66ฮฒ ยท 37% Vol Lower Realized Risk MEDX
Unified Institutional Score Composite Signal 42.6 / 100 (HOLD) 55.3 / 100 (HOLD) Higher Composite GTOP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MEDX vs GTOP Buy Guide
MEDX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MEDX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GTOP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GTOP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MEDX nor GTOP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.